STN: BL 125163
Proper Name: Influenza Vaccine
Tradename: Flulaval Quadrivalent
Manufacturer: ID Biomedical Corporation of Quebec
- For active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.
- FLULAVAL QUADRIVALENT is approved for use in persons aged 6 months and older
- February 6, 2020 Approval Letter - FluLaval
- July 2, 2019 Approval Letter - FluLaval
- June 29, 2018 Approval Letter - FluLaval Quadrivalent
- July 7, 2017 Approval Letter - FluLaval Quadrivalent
To include the 2017-2018 United States formulation and associated labeling revisions.
- Statistical Review and Evaluation - FluLaval and FluLaval Quadrivalent
- Statistical Review Assay - FluLaval and FluLaval Quadrivalent
- Clinical Review - FluLaval and FluLaval Quadrivalent
- Supporting Documents older than three years - FluLaval Quadrivalent